Biopharmaceuticals

Drug Development Product Development Clinical Trials Research and Development Generic Drugs Therapeutics Animal Health FDA Approvals Generic Medicines Teva Pharmaceutical Industries Limited

3 ARTICLES

last wk.

MediWound Posts Weak Q1 but Reaffirms 2026 Revenue Target as BARDA Deal and Factory Upgrades Drive H2 Plan

A newly announced long-term BARDA procurement pact and scheduled manufacturing changes position the company to rely on government purchases for a second-half revenue ramp.

4 ARTICLES

4w ago

Krystal Biotech Reports Strong Q1 on VYJUVEK, Readies Wider Launches

6 ARTICLES

5mo ago

Telix Investors Face Jan. 9 Deadline in Securities Class Action Tied to SEC, FDA Disclosures

6 ARTICLES

6mo ago

Telix Investors Face Jan. 9 Deadline in Securities Suit Over Drug and Manufacturing Disclosures

6 ARTICLES

6mo ago

Telix Securities Suit Advances as Investor Firms Push Lead-Plaintiff Bids Before Jan. 9 Deadline

3 ARTICLES

6mo ago

Bristol Myers and J&J Cast as Dividend Plays as Bayer’s FXIa Win Refocuses Pipeline Interest

3 ARTICLES

7mo ago

Abzena, Mabqi Forge Partnership to Link Antibody Discovery With Development and GMP Manufacturing

4 ARTICLES

8mo ago

Lilly Steps Up Obesity Push With San Diego Innovation Hub and $6.5 Billion Houston Factory

8 ARTICLES

8mo ago

PGIM Jennison’s Q2 Letter Details Health-Care Slide, Portfolio Shifts and Company Catalysts

3 ARTICLES

8mo ago

Insmed's Experimental Drug Brensocatib Achieves Major Trial Success

Biopharmaceuticals

MediWound Posts Weak Q1 but Reaffirms 2026 Revenue Target as BARDA Deal and Factory Upgrades Drive H2 Plan

Krystal Biotech Reports Strong Q1 on VYJUVEK, Readies Wider Launches

Telix Investors Face Jan. 9 Deadline in Securities Class Action Tied to SEC, FDA Disclosures

Telix Investors Face Jan. 9 Deadline in Securities Suit Over Drug and Manufacturing Disclosures

Telix Securities Suit Advances as Investor Firms Push Lead-Plaintiff Bids Before Jan. 9 Deadline

Bristol Myers and J&J Cast as Dividend Plays as Bayer’s FXIa Win Refocuses Pipeline Interest

Abzena, Mabqi Forge Partnership to Link Antibody Discovery With Development and GMP Manufacturing

Lilly Steps Up Obesity Push With San Diego Innovation Hub and $6.5 Billion Houston Factory

PGIM Jennison’s Q2 Letter Details Health-Care Slide, Portfolio Shifts and Company Catalysts

BMO Raises AbbVie Target to $240 After Rinvoq Generic Dispute Is Resolved

Teva Wins FDA Fast Track for Emrusolmin in Multiple System Atrophy

Biohaven Investors Face Sept. 12 Deadline in Securities Class Action

Neumora’s Depression Drug Fails to Meet Goals in Key Phase 3 Trial

Insmed's Experimental Drug Brensocatib Achieves Major Trial Success